Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice Nayoun KimKeon-Il ImSeok-Goo Cho Review Article 31 May 2013 Pages: 1295 - 1308
De novo AML patients with favourable–intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened “GO question” Marino ClavioFabio CrucianiMarco Gobbi Original Article 18 May 2013 Pages: 1309 - 1318
Rapid detection of IDH2 (R140Q and R172K) mutations in acute myeloid leukemia Saquib AshrafNélida I. NogueraFrancesco Lo-Coco Original Article 15 August 2013 Pages: 1319 - 1323
Centrosome aberrations in bone marrow cells from patients with myelodysplastic syndromes correlate with chromosomal instability Florian NolteMichelle GiehlAlice Fabarius Original Article 05 May 2013 Pages: 1325 - 1333
The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes Bin FuChi Young OkSa A. Wang Original Article 10 May 2013 Pages: 1335 - 1343
Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib Paul La RoséePhilippe MartiatAndreas Hochhaus Original Article 28 April 2013 Pages: 1345 - 1350
Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab Zi-Zhen XuZu-Guang XiaJun-Min Li Original Article 02 May 2013 Pages: 1351 - 1358
Assessing DcR3 expression in relation to survivin and other prognostic factors in B cell non-Hodgkin’s lymphoma Ahmed M. L. BedewyMaha M. Adel ElgammalShereen M. EL-Maghraby Original Article 08 May 2013 Pages: 1359 - 1367
The role of 18F-fluorodeoxyglucose positron emission tomography at response assessment after autologous stem cell transplantation in T-cell non-Hodgkin’s lymphoma patients Byeong Seok SohnDok Hyun YoonCheolwon Suh Original Article 21 May 2013 Pages: 1369 - 1377
Feasibility of clofarabine cytoreduction followed by haploidentical hematopoietic stem cell transplantation in patients with relapsed or refractory advanced acute leukemia Johanna TischerHans Joachim StemmlerAndreas Hausmann Original Article 09 August 2013 Pages: 1379 - 1388
Allogeneic hematopoietic cell transplantation with reduced-intensity conditioning following FLAMSA for primary refractory or relapsed acute myeloid leukemia Dominik SchneidawindBirgit FedermannWolfgang Andreas Bethge Original Article 08 May 2013 Pages: 1389 - 1395
Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia Marta KrejciMichael DoubekJiri Mayer Original Article 01 June 2013 Pages: 1397 - 1403
Guidelines for the use of long-term central venous catheter in children with hemato-oncological disorders. On behalf of supportive therapy working group of Italian Association of Pediatric Hematology and Oncology (AIEOP) F. CarraroM. P. CicaleseM. Giacchino Original Article 16 June 2013 Pages: 1405 - 1412
Azacitidine as salvage therapy in elderly patients with relapsed acute myeloid leukemia after autologous transplantation Massimo BrecciaAdriano SalaroliGiuliana Alimena Letter to the Editor 20 March 2013 Pages: 1413 - 1414
A case of late onset erythropoietic protoporphyria associated with myelodysplastic syndrome treated by the combination of beta carotene and azacitidine Yoshitaka NishikawaShinya OkudaKazuhiko Kobayashi Letter to the Editor 09 March 2013 Pages: 1415 - 1416
Acute vesiculobullous hand dermatitis and anagen effluvium in Ganoderma lucidum-induced aplastic crisis Min Ju ChoiDo-Young KimSung Bin Cho Letter to the Editor 10 March 2013 Pages: 1417 - 1419
Disseminated plasmacytomas in multiple myeloma: atypical presentations on multimodality images, emphasized on PET/CT Jingwei YiShengjun WangJing Wang Letter to the Editor 21 March 2013 Pages: 1421 - 1423
Pure red cell aplasia associated with CD20+ myeloma: complete remission with rituximab Chi-Chiu SoWilliam W. L. ChoiYok-Lam Kwong Letter to the Editor 14 March 2013 Pages: 1425 - 1426
Optic neuritis preceding progressive outer retinal necrosis in an immunocompromised patient after allogeneic stem cell transplantation Amit PatelEduardo Olavarria Letter to the Editor 13 February 2013 Pages: 1427 - 1429
Necrotic and ulcerated cutaneous and mucosal leukemia cutis in AML6 Claude BachmeyerMarc BuffetSélim Aractingi Letter to the Editor 01 March 2013 Pages: 1431 - 1432
Novel FGFR3 rearrangement t(4;22)(p16;q11.2) in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma Jan CernyHongbo YuPatricia M. Miron Letter to the Editor 13 April 2013 Pages: 1433 - 1435
Life-threatening bleeding tendency provoked by an acquired isolated factor X deficiency associated with respiratory infection L. CouckeS. TrensonK. Devreese Letter to the Editor 06 March 2013 Pages: 1437 - 1438
